Freedom Bio

Developer of next-generation pharmaceuticals for neuropsychiatric conditions and substance use disorders

placeLos Angeles, California, United States calendar_todayFounded 2021 groups7 employees language freedombio.co

Innovation

1 patent family — focus: Human necessities; filing pace active.

YearFilings
20241

Investor mix

9 investors on record; lead investors include MBX Capital, LongeVC.

Investor typeCountShare
Venture capital778%
Angel & family office111%
Other / undisclosed111%
Coming soon